VEGFA and gastric cancer: Furthermore, the G/G genotype of the VEGF-634 G/C polymorphism is associated with higher serum expression levels of VEGF and a poor clinical outcome in patients with advanced gastric cancer who are treated with oxaliplatin, 5-FU and leucovorin (103).